The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays.
about
Genetic relationship between Cryptococcus neoformans var. neoformans strains of serotypes A and DCharacterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.Role of the Apt1 protein in polysaccharide secretion by Cryptococcus neoformans.Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages.Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates.Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrationsIn vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.Antibody interactions with the capsule of Cryptococcus neoformansDual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in IndiaEffects of voriconazole on Cryptococcus neoformans.Antibodies produced in response to Cryptococcus neoformans pulmonary infection in mice have characteristics of nonprotective antibodiesA Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan.Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct.Multiple Disguises for the Same Party: The Concepts of Morphogenesis and Phenotypic Variations in Cryptococcus neoformansThe relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response.Fungal virulence in a lepidopteran model is an emergent property with deterministic featuresThe capsule of the fungal pathogen Cryptococcus neoformans.Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) isolates in New York City.Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure.Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies.Monoclonal antibody 13F1 produces annular immunofluorescence patterns on Cryptococcus neoformans serotype AD isolatesBinding of glucuronoxylomannan to the CD14 receptor in human A549 alveolar cells induces interleukin-8 production.Cryptococcal pathogenic mechanisms: a dangerous trip from the environment to the brain.
P2860
Q33674974-84C7744E-0CC2-4157-9972-2EA2076645D3Q33693515-D2A12815-5140-4AC4-9EDC-739C9752246FQ33743568-0473D881-2A77-418D-8C5C-645C21109102Q33953082-D63986AC-0206-4918-BAF1-7D8DA7A1CFCAQ33959465-EFEF5B1A-A9E1-4EE2-82BE-4C28C512E4ECQ33975989-07F43922-5F9B-4BC3-9AE2-55025FDC5B66Q34001243-5BA25D32-8BAF-43CA-8A25-C0B9FB19C00CQ34004832-E67BD7C5-406D-4926-B85C-125FABE25C39Q34042463-80D5B9F1-3B18-4717-B9DF-0619717F3994Q34142180-742C2A07-7130-488C-8447-543CAC69EDDDQ34757345-81B1D1CC-A047-4867-9D2F-5A994D4708E4Q34907746-0DF51349-1A55-4DD7-AA50-094C7F6FC181Q34961105-E9F5B7DF-EC2C-4D72-A5EF-2E4F780ACD31Q35197055-660EBCCF-37EC-4551-B7F6-EC89A8A17F44Q35913526-99945CEF-BEE2-46F8-BC60-7E4F9AC1D58FQ36829216-EBC5C9B6-A1F3-47E2-8098-02D849EFDEF4Q37337879-C3D4D74F-21E6-4A61-953B-5E2611300FD1Q39457535-FE53627A-93CC-4B71-A174-9B2EAD8ED619Q39512897-62E3EC7C-EE98-4094-AD1F-213CFE0C36F6Q39520077-14DB18B4-9E40-4C8F-90FA-BF0FE245430CQ42725627-78ABCB04-2588-44D4-BFEC-AC7492B485C4Q42956866-0B73888A-2881-4325-BE0E-F349EED0C124Q52580472-2403F504-18EC-40CF-AC7E-E2FCEC0194D6
P2860
The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The different binding patterns ...... ferences in functional assays.
@ast
The different binding patterns ...... ferences in functional assays.
@en
type
label
The different binding patterns ...... ferences in functional assays.
@ast
The different binding patterns ...... ferences in functional assays.
@en
prefLabel
The different binding patterns ...... ferences in functional assays.
@ast
The different binding patterns ...... ferences in functional assays.
@en
P2860
P1476
The different binding patterns ...... fferences in functional assays
@en
P2093
A Casadevall
P2860
P304
P577
1998-03-01T00:00:00Z